Skip to main content

Table 1 Characteristics of included Studies on causes of LBP

From: Failure to define low back pain as a disease or an episode renders research on causality unsuitable: results of a systematic review

First author, Year, Country

Study design

Anticipated finding(s) based on the study aim(s)

Recall period for LBP Definitiona

According to authors or obvious from text:

1st time episode, Episode, or Prevalence b

Definition of preceding non-episodec

Risk factor data collected prior to the onset of LBP variable

Aggarwal 2013

India [28]

Cross-sectional

Prevalence, associated risk factors

1 year

Prevalence

None

No

Alperovitch 2010

Israel [29]

Cross-sectional

Prevalence, associated risk factors

1 year

Prevalence

None

No

Auvinen 2010

Finland [30]

Longitudinal

Risk factors

6 month

Episode

No LBP previous 6 month at 16 & 18

Yes for the 2nd survey

Capkin 2015

Turkey [31]

Cross-sectional

Prevalence, risk factors

Lifetime, 1 year

Prevalence

NA

No

Cho 2012

South Korea [32]

Cross-sectional

Prevalence, risk factors

Lifetime, Point, 6 month

Prevalence

NA

Not clear

Coenen 2013

the Netherlands [33]

Prospective cohort

Associated risk factor

1 year

Prevalence

NA

Not clear

Erick 2014

Botswana [34]

Cross-sectional

Prevalence, risk factors

1 year

Prevalence

NA

No

Ernat 2012

North America [35]

Retrospective, Database analysis

Incidence, risk factors

NA

Initial visit for lumbago

NA

No

Gaowgzeh 2015

Saudi Arabia [36]

Cross-sectional

Prevalence, risk factors

Undefined

Prevalence

None

No

Jia 2016

China [37]

Cross-sectional

Prevalence, risk factors

1 year

Prevalence

NA

No

Kanchanomai 2015

Thailand [38]

Prospective

Annual incidence, risk factors

3 month

Incidence

None

Not clear

Katsavouni 2014

Greece [39]

Cross-sectional

Risk factors

1 year

Prevalence

NA

No

Knox 2014

North America [40]

Retrospective Database analysis

Incidence, risk factors

NA

First diagnosis of LBP

NA

No

Lin 2014

Taiwan [41]

Cross-sectional

Prevalence, risk factors

1 year

Prevalence

NA

No

Lin 2012

Taiwan [42]

Cross-sectional

Prevalence, risk factors

Lifetime, point

Prevalence

NA

No

Mikkonen 2016

Finland [43]

Prospective cohort

Risk factors

6 month

Episode

No LBP past 6 month at 16 & 18

Yes for the 2nd survey

Mitchell 2010

Australia [44]

Prospective

Risk factors predicting new-onset LBP

Life-time, 1 year

Episode

No significant LBP at baseline

Yes

Mohseni-bandpei 2011

Iran [45]

Cross-sectional

Prevalence, risk factor

Point, 1 month, 6 month, year, lifetime

Prevalence

NA

No

Murtezani 2011

Kosovo [46]

Cross-sectional

Prevalence, risk factors

1 year

Prevalence

NA

No

Ng 2014

Australia [47]

Cross-sectional

Prevalence, risk factors

Lifetime, point

Prevalence

NA

No

Nissen 2014

Denmark [48]

Retrospective

Associated Risk factors

1 year

Prevalence

NA

No

Noda 2015

Sri Lanka [49]

Cross-sectional

Prevalence, risk factors

4 weeks

Prevalence

NA

No

Ramond-Roquin 2015 France [50]

Prospective cohort

Risk factors

1 week

Prevalence, episode

NA

Yes for the 2nd survey

Shemory 2016

North America [51]

Retrospective Database analysis

Risk factors

NA

Incidence

NA

No

Sikiru 2010

Nigeria [52]

Cross-sectional

Prevalence, risk factors

1 year

Prevalence

NA

No

Steffens 2015

Australia [53]

Case-crossover

Risk factors

NA

Episode

Free of pain in the past month

No/purposely retrospective

Sterud 2013

Norway [54]

Prospective

Risk factors

4 weeks

Prevalence

NA

No

Triki 2015

Tunisia [55]

Retrospective

Prevalence

No LBP before current injury

First LBP injury

NA

No

van Hilst 2015

the Netherlands [56]

Cross-sectional

Prevalence, associated risk factors

1 year

Prevalence

NA

No

Vandergrift 2012

North America [57]

Prospective

Risk factors

1 year

Episode

Pain-free at baseline

Yes for the follow-up survey

Vargas-Prada 2013

Spain [58]

Prospective

Incidence, risk factors

1 year

Episode

Free of pain in the past month

Yes for the follow-up survey

Vilar Furtado 2014

Brazil [59]

Cross-sectional

Risk factors

3 month

Prevalence

NA

No

Yue 2012

China [60]

Cross-sectional

Prevalence, risk factors

1 year

Prevalence

NA

No

  1. aThe period in which an episode of LBP was investigated for its risk factors
  2. b1st time episode: when the very first episode of LBP was investigated, Episode: when any pain-free period preceding the recurrent episode under scrutiny could be identified, and Prevalence: when explicitly stated by authors or based on their objectives and method a mixture of all types of LBP was investigated
  3. cAn application of a pain-free period preceding the episode under scrutiny